English
Home > Products > Sacubitril Valsartan

China Sacubitril Valsartan Factory

Our purpose would be to give good quality items at competitive rates, and top-notch service to consumers around the world. We are ISO9001, CE, and GS certified and strictly adhere to their quality specifications for Sacubitril Valsartan,CAS NO:936623-90-4,Sacubitril Valsartan API,Sacubitril API,Valsartan API, Never-ending improvement and striving for 0% deficiency are our two main quality policies. Should you need anything, never hesitate to get in touch with us.
Sacubitril Valsartan, All styles appear on our website are for customizing. We meet up to individual requirements with all solutions of your very own styles. Our concept is to help presenting the confidence of each buyers with the offering of our most sincere service, and the right product.

Related Products

Hot Products

  • LY 2784544

    LY 2784544

    Product Name:LY 2784544
    Molecular Formula:C23H25ClFN7O
    Molecular Weight;469.94
    CAS Registry Number;1229236-86-5
  • Oxymetholone

    Oxymetholone

    Product Name:Oxymetholone
    Molecular Formula:C21H32O3
    Molecular Weight:332.48
    CAS Registry Number:434-07-1
  • 2,3-Difluorobenzyl alcohol

    2,3-Difluorobenzyl alcohol

    Product Name:2,3-Difluorobenzyl alcohol
    Molecular Formula:C7H6F2O
    Molecular Weight:144.12
    CAS Registry Number:75853-18-8
  • Hexamethyldisilazane

    Hexamethyldisilazane

    Product Name:Hexamethyldisilazane
    Molecular Formula:C6H19NSi2
    Molecular Weight:161.39
    CAS Registry Number:999-97-3
  • 3-oxo-1,3-dihydroisobenzofuran-1-ylphosphonic acid

    3-oxo-1,3-dihydroisobenzofuran-1-ylphosphonic acid

    Product Name:3-oxo-1,3-dihydroisobenzofuran-1-ylphosphonic acid
    Molecular Formula:C10H11O5P
    Molecular Weight:242.17
    CAS Registry Number:61260-15-9
  • Iberdomide

    Iberdomide

    Product Name:Iberdomide
    Molecular Formula:C25H27N3O5
    Molecular Weight;449.5
    CAS Registry Number;1323403-33-3
  • Related Blog
  • Reviews

  • How to find the best China API manufacturer?

    Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • What is Coenzyme Q10 CAS NO.303-98-0

    Coenzyme Q10 (CAS NO.303-98-0 ) is a fat-soluble antioxidant, which can activate the nutrition of human cells and cellular energy, and has the functions of improving human immunity, enhancing antioxidation, delaying ageing and enhancing human vitality.

  • Gilteritinib Fumarate

    Sandoo Pharmaceutica is a professional pharmaceutical intermediates manufacturer. We provide good quality Gilteritinib Fumarate Cas: 1254053-43-4. Welcome and we look forward to your inquiry!

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Related Search

Sacubitril Valsartan API

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept